In this guide
A headline with "keto" and "cancer" in the same sentence travels much faster than the paper behind it. If your feed has been full of it since early October, you've probably seen at least three versions: "Keto fuels tumours", "Keto protects the gut", and "Scientists baffled". All three are partly right, and all three skip the details that decide whether you should care.
Here's the timeline. MIT researchers published the study in Nature on 15 July 2026. The MIT news office covered it that day, and outlets like Newsweek and the New York Post followed within hours. Then ScienceDaily republished a summary on 5 October, and a fresh wave of social posts treated it as brand-new. So some of what you're seeing is the second lap of a three-month-old story. That's useful context, because it means there's already been time for experts to react.
We read the coverage, the MIT release and the secondary analyses so you don't have to wade through the hype. The honest takeaway is more interesting than either extreme.
The short version: in mice engineered to be prone to intestinal tumours, a ketogenic diet increased tumours in the small intestine (at rates similar to, or higher than, an obesity-inducing high-fat diet, even though the keto mice stayed lean) while reducing tumours in the colon. The effects were traced to how intestinal stem cells burn dietary fat, not to ketones. The work was done in mice, not humans, and the researchers and independent commentators stress it isn't a basis for dietary recommendations.
Why This Headline Is Back in Your Feed
Keto remains one of the most-searched diets in the world, so any claim about its safety gets amplified quickly. This study also arrives at a sensitive moment. Over the last few years, the keto conversation has shifted from "does it work for weight loss?" to "what happens if you stay on it for years?", a question the research hasn't been able to answer well. Long-term human data are thin, so mechanistic studies in animals fill the gap and sometimes get read as if they were human findings.
There's also a plot twist that makes this study more newsworthy than a plain "keto is risky" paper. A well-known 2022 study had suggested that a ketone body called beta-hydroxybutyrate (BHB) protects against colorectal cancer, giving keto fans a headline of their own. The new work doesn't simply contradict that. It complicates the story and challenges the explanation.
The Study at a Glance
Item | Details |
|---|---|
Title | "Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones" |
Journal and date | Nature, 15 July 2026 (Shay et al.); widely re-circulated from 5 October 2026 |
Senior author | Γmer Yilmaz, associate professor of biology at MIT and director of its Stem Cell Initiative |
Model | Mice genetically engineered to be predisposed to intestinal cancer (a defective copy of a gene that normally restrains it) |
Diets compared | Ketogenic diet, standard control diet, and a high-fat, high-calorie "obesogenic" diet |
Duration | Roughly 150 days |
Small intestine | More tumours on keto than control; similar to or higher than the obesogenic diet; keto-fed mice also died sooner |
Colon | Keto suppressed tumours |
Proposed mechanism | Fat metabolism within intestinal stem cells, not the ketone bodies themselves |
Human data | None in this study |
What Actually Happened in the Lab
The team wanted to know whether keto's reported protection against colon cancer extends to the rest of the gut. They fed cancer-prone mice one of three diets for roughly five months: a ketogenic diet, a standard control diet, or the sort of fat-heavy, calorie-dense diet that is normally used to make mice obese.
Two results stood out. First, mice on the ketogenic diet developed more small-intestine tumours than mice on the control diet, and at rates comparable to, or even higher than, mice on the obesity-inducing diet. Second, the keto mice did not become obese. That detail matters, because it means the extra tumours can't be blamed on weight gain. Something about the diet's fat-fuelling pattern, rather than body fat, seemed to be driving it.
Two Neighbouring Organs, Opposite Results
The colon told the opposite story. In the same animals, on the same diet, tumours were suppressed. That's a striking result because it echoes earlier work suggesting keto might protect the colon. It also shows how strongly a tissue's local biology shapes its response to a diet. The small intestine and the colon sit next to each other, handle very different jobs, and apparently respond to the same fuel in opposite ways.
For readers, the useful insight is that "keto and cancer" isn't one question. It's a family of tissue-specific questions, and a blanket statement like "keto causes cancer" or "keto prevents cancer" is almost certainly wrong in both directions.
Lipids, Not Ketones: Why the Mechanism Is the Real News
This is the part most coverage rushed past. Ketone bodies such as BHB are the molecules that give ketosis its name, and they have been the star of the keto story, both in marketing and in the earlier colon-cancer research. In this study, the team found that both the tumour-promoting effect in the small intestine and the tumour-suppressing effect in the colon tracked with how cells handle dietary fat, not with ketones. Lead researcher Yilmaz described the ketones as essentially bystanders in this setting.
They also looked at a receptor that a competing explanation had credited for keto's colon benefit, a sensor for the ketone BHB. It turned out to be missing from the tumours and absent from the stem cells in question. In plain English: the receptor you'd need if ketones were doing the work wasn't there to do it.
Why does this matter for ordinary people? Because it shifts attention from "being in ketosis" to "what the diet is made of". A diet can raise ketones and still push fat-burning pathways in stem cells in ways that differ by tissue. It also suggests that the type, amount and context of dietary fat probably matter more than the ketone reading on a test strip.
Stem Cells: A Repair-Versus-Cancer Trade-Off
The lining of your small intestine renews itself every few days, and intestinal stem cells do the work. According to the MIT team, the ketogenic diet made those stem cells more active. More active stem cells mean better repair after injury, which sounds like a good thing. But every cell division is another chance for a copying mistake, so in an animal already carrying a cancer-promoting genetic defect, more division can lead to more tumours. Yilmaz summarised the trade-off in almost those words: more stem cells improve repair but raise the chance of tumour formation.
This connects to earlier work from the same lab. A 2016 Nature paper by Beyaz and colleagues found that a high-fat diet enhanced the stemness and tumour-forming ability of intestinal progenitor cells. The 2026 study extends that line of thinking by showing a keto diet can produce a similar stem-cell effect in the small intestine, even without obesity, while behaving very differently in the colon.
How Far Can You Stretch a Mouse Study?
Not as far as headlines tend to. Here are the translation problems we'd keep in mind:
The mice were predisposed. They carried an engineered genetic defect that makes intestinal tumours likely. Most people don't. A diet that tips the balance in a high-risk animal may do little in a low-risk one.
Mouse gut tumour patterns differ from human ones. In many widely used mouse models of intestinal cancer, tumours cluster in the small intestine. In people, inherited predisposition syndromes more often produce colorectal tumours, and small-intestine cancer is rare overall. That mismatch is one reason mouse findings need careful translation.
Rodent keto diets are extreme. They're usually formulated with an exceptionally high fat share, often higher than people eat. The exact formulation in the paper is worth checking before comparing it with a human keto plate.
Mouse time isn't human time. About 150 days is a large slice of a mouse's life. It's not the same as five months of a person's eating.
No human outcomes were measured. The study doesn't tell us whether people on keto develop more or fewer small-intestine tumours.
That's why independent summaries of the work state plainly that it doesn't provide a basis for dietary recommendations. Think of it as a well-built signal worth following up, not a verdict.
What This Means for Ketone Supplements
One practical implication is clear from the authors' own framing: because both the risk and the benefit in this study came from fat metabolism rather than ketones, ketone drinks and powders wouldn't be expected to reproduce either effect. If you've been wondering whether sipping a ketone supplement would give you "the benefits of keto without the diet", this study adds another reason to be sceptical. We cover the broader evidence in our earlier piece on exogenous ketones and what they can and can't do.
Zooming Out: What the Keto Evidence Looks Like Overall
Area | Where the evidence stands |
|---|---|
Short-term weight loss | Reasonable evidence over months, mostly through reduced appetite and calorie intake |
Blood sugar in type 2 diabetes | Short-term improvements are well documented; needs medical supervision if on glucose-lowering drugs |
Drug-resistant epilepsy | Established, supervised medical therapy |
Cholesterol and heart markers | Variable; some people see large LDL rises (see our guide to the lean mass hyper-responder pattern) |
Athletic performance | Depends on the sport; weaker for high-intensity work |
Long-term cancer outcomes in humans | Not established either way; animal findings now differ by gut region |
If you want a refresher on building a sensible keto plan, our guides on calculating net carbs, fat and protein and the keto macro calculator walk through the basics.
Who Should Talk to a Doctor Before Staying on Keto
This section is our editorial judgement, not a claim made by the study. Because the mice were genetically predisposed, the closest human parallel would be people with inherited conditions that raise intestinal cancer risk. If any of the following applies, it's reasonable to ask a gastroenterologist or your GP about long-term keto before committing:
An inherited polyposis or hereditary cancer syndrome (for example, familial adenomatous polyposis or Lynch syndrome)
Crohn's disease or other long-standing small-bowel inflammation
A personal or close-family history of intestinal or colorectal cancer
Unexplained gut symptoms that haven't been investigated
For everyone else, the study isn't a reason to abandon a plan that's working. It's a reason to treat "how long" and "what kind of fat" as real questions.
Calm, Practical Steps if You're on Keto Now
Don't panic, and don't ignore it. One mouse study doesn't change human risk much, but it's a fair prompt to review your approach.
Focus on diet quality inside keto. Prioritise olive oil, nuts, fish and plenty of non-starchy vegetables over processed meats and heavily refined fats. Fibre from vegetables matters for gut health whatever your macros.
Consider cycling or periodic breaks. Longer-term keto is the question mark, not a few months. Our piece on how long to stay on keto covers cycling and transitions, and you can recalculate your targets with the keto macro calculator and carb calculator.
Keep up with routine screening. Colorectal screening is generally recommended from around age 45β50 depending on the country (45 in the US). Diet isn't a substitute for it.
Know the warning signs. Persistent abdominal pain, blood in the stool, unexplained weight loss, new anaemia or a lasting change in bowel habits all deserve a doctor's visit regardless of your diet.
The Bottom Line
This is good science that points in an unexpected direction, and it deserves a careful read rather than a shrug or a scare. Two takeaways stand out. First, the same diet can push neighbouring tissues in opposite directions, so blanket statements about keto and cancer are likely to be wrong. Second, the biology appears to hinge on fat metabolism rather than ketones, which should make all of us more cautious about treating a ketone reading as a proxy for "healthy".
What it isn't is a human study. Until researchers follow people on long-term ketogenic diets and track gut outcomes, the safest stance is informed caution: choose quality fats, don't treat keto as a permanent default without checking in on your health, and speak to a clinician if you carry a higher baseline risk.
Frequently Asked Questions
Does the keto diet cause cancer?
No human study shows that. The new Nature paper found that a ketogenic diet increased small-intestine tumours in genetically cancer-prone mice, and decreased colon tumours in the same animals. It was an animal study, and the authors and commentators stress it doesn't establish risk for people.
Why did keto reduce colon tumours but increase small-intestine tumours?
The researchers traced both effects to how intestinal stem cells handle dietary fat. The two organs seem to respond differently to the same fuel. Exactly why isn't yet understood, and the team says it wants to study it further.
Is this about ketones or about fat?
According to the study, fat metabolism. The authors describe ketones as bystanders in this setting, and a receptor proposed to explain keto's colon benefit through ketones was missing from the tumours and stem cells examined.
Would ketone supplements carry the same risk?
The authors' framing suggests no, because the effects came from fat metabolism rather than ketones. That also means ketone supplements wouldn't be expected to provide the colon benefit seen in mice.
Should I stop keto because of this study?
Most healthy people don't need to stop because of one mouse study. If you have an inherited cancer syndrome, long-term bowel disease or a strong family history of intestinal cancer, it's sensible to discuss long-term keto with a doctor. Everyone should keep up with standard screening.
Are small-intestine cancers common?
No. They're rare compared with colorectal cancer, accounting for only a small percentage of gastrointestinal cancers. That's one reason translating mouse small-intestine results to human risk is difficult.
Does a high-fat diet without ketosis carry the same concern?
In this study, the obesity-inducing high-fat diet also produced small-intestine tumours at high rates, which fits earlier work linking high-fat diets to increased intestinal stem-cell activity. So the signal isn't unique to ketosis.
What kinds of fat are safest on keto?
The study didn't compare fat types, so we can't claim a "safe" fat from it. General dietary guidance favours unsaturated fats from olive oil, nuts and fish over processed meats and highly refined fats, which is a sensible default inside any low-carb plan.
How long can I safely stay on keto?
There's no single research-backed answer, because long-term human data are limited. Many practitioners suggest periodic reassessment, cycling or breaks, and individual monitoring of symptoms and bloodwork rather than treating keto as an indefinite default.
References & Sources
Shay, J. et al., and Yilmaz, Γ. H. (2026). Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones. Nature.
MIT News Office (15 July 2026). Ketogenic diets may increase cancer risk in the small intestine.
ScienceDaily (5 October 2026). MIT scientists find a hidden cancer risk of the keto diet.
Dmitrieva-Posocco, O. et al. (2022). Ξ²-Hydroxybutyrate suppresses colorectal cancer. Nature, 605, 160β165.
Beyaz, S. et al. (2016). High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature, 531, 53β58.
US Preventive Services Task Force (2021). Screening for colorectal cancer: recommendation statement. JAMA, 325(19), 1965β1977.
MacrosMeasure (2026). Free Keto Macro Calculator.
Calculate your own numbers β free.
18 science-backed calculators covering everything in this article and more.